Home Noticias de Salud Family Centers Health Centers Resources My Health Manager
  Search
  PersonalMD Services  
  Family Health
  Women's Health
  Children's Health
  Men's Health
  Senior's Health
   
  Health Centers
  Alternative Medicine
  Cardiac Care Center
  Cancer Center
  Emergency Dept
  Medical Advances
  Nutrition Central
  Pulmonary Center
  Sports Medicine
  Travel Medicine
   
  Resources
  Drug Interaction
  Drugs & Medications
  Health Encyclopedia


     
   
Allergy shots save money in the long run, researcher says

By Karla Harby

NEW YORK, Aug 21 (Reuters Health) - Allergy shots for year-round hay fever or hay fever with asthma do save money over time, even though such injections are costly and must be given for several years, according to a researcher from the Emory School of Medicine in Atlanta.

The reason is that without the shots, hay fever and asthma sufferers take medications to relieve their symptoms, and some of these drugs are quite expensive, explained Dr. Timothy J. Sullivan. "We're looking at decades of disease, mountains of medications," he said.

For example, people with moderately severe, perennial hay fever--that is, allergic rhinitis caused by substances that are in the air year-round, such as animal dander, dust mites or molds--will spend approximately $1,200 a year for medications, for a total cost of $7,200 after six years. A series of allergy shots (also called allergy vaccination or specific immunotherapy) will cost $1,480 to $1,960 after six years.

Assuming that immunotherapy reduces the medication expense over the years, but never completely eliminates it, the cost savings after six years will be $2,940 to $3,350, Sullivan said. Using similar assumptions, he found that those who have perennial allergic rhinitis plus asthma, who normally spend even more on medications, will save $6,750 to $7,620 after six years.

By contrast, those who suffer from hay fever symptoms only in the summer will spend $220 or $730 more in a six-year period if they opt for allergy shots instead of anti-histamines and other medications, according to Sullivan's analysis.

In some patients, immunotherapy eliminates the need for medications entirely, in which case the cost savings would be greater, Sullivan added. He also did not take into account the costs of quality of life considerations, such as time lost from work or school because of allergic reactions and their associated costs. Sullivan reported his findings here at a consensus conference sponsored by the American College of Allergy, Asthma & Immunology and St. Luke's-Roosevelt Hospital Center.


DISCUSSION
See what PersonalMD members have to say about this article.
 

 

 

 

Register About Us Emergency Contact us Privacy Policy Help Center
Resources Health Centers Family Health